Sound Blade Medical

Sound Blade Medical

Private
Halifax, Nova ScotiaHealthcare & Life Scienceshttps://soundblademedical.com

Last Round

Series A

Jan 29, 2025

Total Funding Raised

$16.5M

Momentum Score

50 /100

Company Overview

Sound Blade Medical, Inc. is a medical device company founded in 2023 and based in Halifax, Nova Scotia. The company is developing a breakthrough handheld histotripsy technology that uses focused ultrasound to mechanically and non-invasively liquefy targeted tissue without causing thermal damage. This innovative platform, guided by real-time imaging, aims to replace traditional surgical methods across a variety of medical conditions by offering benefits such as reduced blood loss, fewer complications, and faster recovery times. The technology is currently for investigational use and not for sale. In January 2025, the company secured $16.5 million in a Series A funding round to advance the development and clinical validation of its technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

histotripsyfocused ultrasoundnon-invasive surgerytissue ablationhandheld medical deviceultrasound ablationtumor ablationfocused ultrasound surgerymedical devicenon-thermal ablationmedtechliver tumor treatmentclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sound Blade Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Sound Blade Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJan 29, 2025
GrantSep 23, 2024

Key People

Founding team and executive leadership

Jeremy Brown

CEO And Co-Founder

Founding Team

Neil B.

Chief Executive Officer

Executive Team

Sound Blade Medical Investors

Notable investors and investment history

InvestorRounds
Amzak HealthSeries A
Lumira VenturesSeries A
Invest Nova ScotiaSeries A
INOVAITGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors grew 558% MoM.

  • Jul 31, 2025

    Neil Barman, M.D. appointed as new Chief Executive Officer.

Sound Blade Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sound Blade Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sound Blade Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersHalifax, Nova Scotia
Employee Range17
Year Founded2023
Last FundingJan 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.